Flickr / Cannabis Pictures / (CC BY 2.0)
MedReleaf Corp. (TSX:LEAF) is the latest cannabis stock to hit the TSX. The stock initially got an unpleasant smack in the face since the IPO happened last Wednesday in the midst of a nasty industry-wide sell-off. At the time of writing, the stock rallied back to around its IPO share price of $9.50.
Could MedReleaf be the spark to reignite the second wave of the green rush? Or will it become a victim of a sell-off?
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, decreased 11% in August.
On Sept. 6, 2017, organizers behind Cannabis World Congress & Business Expositions announced that the events in Los Angeles and Boston would no longer feature political provocateur Roger Stone as keynote speaker. The announcement comes after weeks of outrage and threats of boycott from marijuana organizations over Stone’s inclusion.
On Sept. 6, 2017, the House Rules Committee decided to block the House of Representatives from voting on an amendment to protect medical marijuana in states that have legalized it.
